ALS Education Specialist

I’m Erica, your ALS Education Specialist.

ALS Education Specialist

I'm still available to chat.


Get answers about starting RADICAVA®
Call 1-855-4-JRNY-M8 (1-855-457-6968)

Educational Support
Down arrow icon
Need help?
Talk to someone
who can answer your
important questions

Call toll-free
Learn more

Down arrow icon
Learn how
RADICAVA® may help
Down arrow icon
Talk to your ALS Education Specialist
who specializes in helping you
understand RADICAVA®

Call toll-free
Learn more

Down arrow icon

Talking to Your
Doctor About RADICAVA® (edaravone)

When you're living with ALS, every move matters. As you work with your healthcare provider (HCP), you may often find yourself asking, "So, what's the next move?"

One topic you'll likely discuss is your options for ALS treatment. If you're interested in RADICAVA®, it may be important to discuss this with your HCP as soon as possible.

Get the Talking to Your Doctor guide

You can download a Talking to Your Doctor discussion guide, which may help you explain why you're interested in RADICAVA®. The discussion guide has 3 pages. The first page is for your own personal reference, and the second and third pages are designed to be shared with your HCP at your next appointment.

Investigating Your Benefits Coverage

The first step to receive RADICAVA® is completing a BIF

Whether you and your HCP have decided that RADICAVA® may be right for you, or you’re still considering your treatment options, the first step is to complete a Benefit Investigation and Enrollment Form, or BIF, for short.

Think of a BIF like an application or a request for more information:

  • The BIF lets you and your HCP know if your health plan covers RADICAVA® and your infusion options
  • Completing a BIF is NOT a commitment to start treatment
  • It may be best to have your HCP submit a BIF as early as possible

To complete a BIF, your HCP will need some basic information about you, such as your insurance or financial information. Having this information ready when you arrive at your appointment can help streamline the process for your HCP. And it may help you receive treatment faster, if you and your HCP decide that RADICAVA® is right for you.

Get started by filling out your BIF today

Your HCP will need to complete and sign the BIF. But you can help by filling out part of the form now. To do so, simply:

  • Download a BIF using the button below
  • Enter as much information as you can

If you prefer, you can print out the blank form and fill it out by hand.

When you're finished filling out the BIF:

  1. Review the form to make sure your information is correct
  2. Print it, if you didn't do so earlier (or you can save it and print later)
  3. Sign the form (see Section 5 of the BIF)
  4. Bring it to your HCP

NOTE: The information that you enter in the BIF is not being stored.

Your HCP will complete the rest of the form and send it to the JourneyMate Support Program™. Do NOT send the BIF yourself. Within a few days, an Insurance & Access Specialist will send you and your HCP a summary of your benefits.

Reference: 1. Data on file. Mitsubishi Tanabe Pharma America, Inc.

Important Safety Information

Before you receive Radicava® (edaravone), tell your healthcare provider about all of your medical conditions, including if you:

  • have asthma.
  • are allergic to other medicines.
  • are pregnant or plan to become pregnant. It is not known if Radicava® will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Radicava® passes into your breastmilk. You and your healthcare provider should decide if you will receive Radicava® or breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Radicava®?

  • Radicava® may cause serious side effects, including hypersensitivity (allergic) reactions and sulfite allergic reactions.
  • Hypersensitivity reactions have happened in people receiving Radicava® and can happen after your infusion is finished.
  • Radicava® contains sodium bisulfite, a sulfite that may cause a type of allergic reaction that can be serious and life-threatening. Sodium bisulfite can also cause less severe asthma episodes in certain people. Sulfite sensitivity can happen more often in people who have asthma than in people who do not have asthma.
  • Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives; swelling of the lips, tongue, or face; fainting; breathing problems; wheezing; trouble swallowing; dizziness; itching; or an asthma attack (in people with asthma).
  • Your healthcare provider will monitor you during treatment to watch for signs and symptoms of all the serious side effects.

The most common side effects of Radicava® include bruising (contusion), problems walking (gait disturbance), and headache.

These are not all the possible side effects of Radicava®. Call your healthcare provider for medical advice about side effects. You may report side effects to Mitsubishi Tanabe Pharma America, Inc. at 1-888-292-0058 or FDA at 1-800-FDA-1088 or


Radicava® is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

Please see full Prescribing Information and Patient Information.

For more information about RADICAVA®, call 1-844-772-4548.